Sagent Pharmaceuticals (SGNT) IPO Opens Higher

April 20, 2011 11:06 AM EDT Send to a Friend
Sagent Pharmaceuticals (Nasdaq: SGNT) IPO is open for trading. Shares are trading at $18.11 after pricing an up-sized offering of 5,750,000 shares at $16, the high end of the expected $14-$16 range.

Morgan Stanley, BofA Merrill Lynch, and Jefferies are acting as the joint bookrunners for the offering.

Sagent Pharmaceuticals, founded in 2006, is a specialty pharmaceutical company focused on developing, manufacturing, sourcing and marketing pharmaceutical products, with a specific emphasis on injectable products.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Hot IPOs, IPOs, Trader Talk

Related Entities

Morgan Stanley, Jefferies & Co, Merrill Lynch, Bank of America

Add Your Comment